These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The molecular identity of the TLQP-21 peptide receptor. Sahu BS; Nguyen ME; Rodriguez P; Pallais JP; Ghosh V; Razzoli M; Sham YY; Salton SR; Bartolomucci A Cell Mol Life Sci; 2021 Dec; 78(23):7133-7144. PubMed ID: 34626205 [TBL] [Abstract][Full Text] [Related]
6. Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells. Hannedouche S; Beck V; Leighton-Davies J; Beibel M; Roma G; Oakeley EJ; Lannoy V; Bernard J; Hamon J; Barbieri S; Preuss I; Lasbennes MC; Sailer AW; Suply T; Seuwen K; Parker CN; Bassilana F J Biol Chem; 2013 Sep; 288(38):27434-27443. PubMed ID: 23940034 [TBL] [Abstract][Full Text] [Related]
7. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice. El Gaamouch F; Audrain M; Lin WJ; Beckmann N; Jiang C; Hariharan S; Heeger PS; Schadt EE; Gandy S; Ehrlich ME; Salton SR Mol Neurodegener; 2020 Jan; 15(1):4. PubMed ID: 31924226 [TBL] [Abstract][Full Text] [Related]
8. Changes in VGF and C3aR1 gene expression in human adipose tissue in obesity. Koc G; Soyocak A; Alis H; Kankaya B; Kanigur G Mol Biol Rep; 2021 Jan; 48(1):251-257. PubMed ID: 33306149 [TBL] [Abstract][Full Text] [Related]
9. Identification of a receptor for neuropeptide VGF and its role in neuropathic pain. Chen YC; Pristerá A; Ayub M; Swanwick RS; Karu K; Hamada Y; Rice AS; Okuse K J Biol Chem; 2013 Nov; 288(48):34638-46. PubMed ID: 24106277 [TBL] [Abstract][Full Text] [Related]
10. Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21. Lisci C; Lewis JE; Daniel ZCTR; Stevenson TJ; Monnier C; Marshall HJ; Fowler M; Ebling FJP; Ferri GL; Cocco C; Jethwa PH PLoS One; 2019; 14(8):e0221517. PubMed ID: 31465472 [TBL] [Abstract][Full Text] [Related]
12. TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling. Bresciani E; Possenti R; Coco S; Rizzi L; Meanti R; Molteni L; Locatelli V; Torsello A Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878142 [TBL] [Abstract][Full Text] [Related]
13. Clearance kinetics of the VGF-derived neuropeptide TLQP-21. Guo Z; Sahu BS; He R; Finan B; Cero C; Verardi R; Razzoli M; Veglia G; Di Marchi RD; Miles JM; Bartolomucci A Neuropeptides; 2018 Oct; 71():97-103. PubMed ID: 29958697 [TBL] [Abstract][Full Text] [Related]
14. VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism. Lin WJ; Jiang C; Sadahiro M; Bozdagi O; Vulchanova L; Alberini CM; Salton SR J Neurosci; 2015 Jul; 35(28):10343-56. PubMed ID: 26180209 [TBL] [Abstract][Full Text] [Related]
15. TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β. Cho K; Jang YJ; Lee SJ; Jeon YN; Shim YL; Lee JY; Lim DS; Kim DH; Yoon SY Biochem Biophys Res Commun; 2020 Apr; 524(3):764-771. PubMed ID: 32037089 [TBL] [Abstract][Full Text] [Related]
16. Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity. Cassina V; Torsello A; Tempestini A; Salerno D; Brogioli D; Tamiazzo L; Bresciani E; Martinez J; Fehrentz JA; Verdié P; Omeljaniuk RJ; Possenti R; Rizzi L; Locatelli V; Mantegazza F Biochim Biophys Acta; 2013 Feb; 1828(2):455-60. PubMed ID: 23122777 [TBL] [Abstract][Full Text] [Related]
17. Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism. Rodriguez P; Laskowski LJ; Pallais JP; Bock HA; Cavalco NG; Anderson EI; Calkins MM; Razzoli M; Sham YY; McCorvy JD; Bartolomucci A J Biol Chem; 2024 Jan; 300(1):105549. PubMed ID: 38072064 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells. Molteni L; Rizzi L; Bresciani E; Possenti R; Petrocchi Passeri P; Ghè C; Muccioli G; Fehrentz JA; Verdié P; Martinez J; Omeljaniuk RJ; Biagini G; Binda A; Rivolta I; Locatelli V; Torsello A Front Pharmacol; 2017; 8():167. PubMed ID: 28424618 [TBL] [Abstract][Full Text] [Related]
19. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Bartolomucci A; La Corte G; Possenti R; Locatelli V; Rigamonti AE; Torsello A; Bresciani E; Bulgarelli I; Rizzi R; Pavone F; D'Amato FR; Severini C; Mignogna G; Giorgi A; Schininà ME; Elia G; Brancia C; Ferri GL; Conti R; Ciani B; Pascucci T; Dell'Omo G; Muller EE; Levi A; Moles A Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14584-9. PubMed ID: 16983076 [TBL] [Abstract][Full Text] [Related]
20. TLQP-21 is a low potency partial C3aR activator on human primary macrophages. Li XX; Lee JD; Lee HS; Clark RJ; Woodruff TM Front Immunol; 2023; 14():1086673. PubMed ID: 36776827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]